Karen A Matthews1, J Richard Jennings, Laisze Lee, Dustin Pardini. 1. From the Department of Psychiatry (Matthews, Jennings, Lee), University of Pittsburgh, Pittsburgh, Pennsylvania; and Department of Criminology and Criminal Justice (Pardini), Arizona State University, Tempe, Arizona.
Abstract
OBJECTIVE: Depressive symptoms and major depression predict cardiovascular disease (CVD) and CVD risk factors in adulthood. Evidence regarding the role of depression in the development of CVD risk in youth is minimal. The study evaluated the prospective relationship of depressive symptoms in childhood and adolescence with adult CVD risk factors in black and white men. METHODS: Health behaviors and medical history were measured in 165 black and 146 white men (mean age = 32); a subset in the Pittsburgh area had a fasting blood draw to measure metabolic syndrome and inflammation. Adult CVD risk factors were related to depressive symptoms and childhood socioeconomic status (SES) prospectively measured annually from ages 7 to 16 years, followed by adjustments for adult SES and depressive symptoms. RESULTS: Men with higher depressive symptoms ages 7 to 16 smoked more cigarettes, B = 0.28 (standard error = 0.12), p = .015, and ate fewer servings of fruits and vegetables, B = -0.08 (0.04), p = .040, as adults. The association for smoking was independent of adult depressive symptoms (concurrent) and childhood and adult SES as well as race. Depressive symptoms during childhood were unrelated to the metabolic syndrome or biomarkers of inflammation in adulthood. CONCLUSIONS: Depressive symptoms in childhood may predict later adverse health behaviors in black and white men. No evidence was found for an association between childhood depressive symptoms with metabolic syndrome or inflammation markers at ages approximately 32 years. The nature of the sample and lack of measurement of depressive disorder diagnosis tempers the conclusions, and future research is needed to determine associations with biological measures at later life span phases.
OBJECTIVE:Depressive symptoms and major depression predict cardiovascular disease (CVD) and CVD risk factors in adulthood. Evidence regarding the role of depression in the development of CVD risk in youth is minimal. The study evaluated the prospective relationship of depressive symptoms in childhood and adolescence with adult CVD risk factors in black and white men. METHODS: Health behaviors and medical history were measured in 165 black and 146 white men (mean age = 32); a subset in the Pittsburgh area had a fasting blood draw to measure metabolic syndrome and inflammation. Adult CVD risk factors were related to depressive symptoms and childhood socioeconomic status (SES) prospectively measured annually from ages 7 to 16 years, followed by adjustments for adult SES and depressive symptoms. RESULTS:Men with higher depressive symptoms ages 7 to 16 smoked more cigarettes, B = 0.28 (standard error = 0.12), p = .015, and ate fewer servings of fruits and vegetables, B = -0.08 (0.04), p = .040, as adults. The association for smoking was independent of adult depressive symptoms (concurrent) and childhood and adult SES as well as race. Depressive symptoms during childhood were unrelated to the metabolic syndrome or biomarkers of inflammation in adulthood. CONCLUSIONS:Depressive symptoms in childhood may predict later adverse health behaviors in black and white men. No evidence was found for an association between childhood depressive symptoms with metabolic syndrome or inflammation markers at ages approximately 32 years. The nature of the sample and lack of measurement of depressive disorder diagnosis tempers the conclusions, and future research is needed to determine associations with biological measures at later life span phases.
Authors: Silvia Franco; Nicolas Hoertel; Hugo Peyre; Jorge Mario Rodríguez-Fernández; Frédéric Limosin; Carlos Blanco Journal: Psychiatry Res Date: 2014-12-20 Impact factor: 3.222
Authors: Sandra Louise; Nicole M Warrington; Pamela A McCaskie; Wendy H Oddy; Stephen R Zubrick; Beth Hands; Trevor A Mori; Laurent Briollais; Sven Silburn; Lyle J Palmer; Eugen Mattes; Lawrence J Beilin Journal: Prev Med Date: 2012-03-16 Impact factor: 4.018
Authors: William E Copeland; Lilly Shanahan; Carol Worthman; Adrian Angold; E Jane Costello Journal: Biol Psychiatry Date: 2011-11-01 Impact factor: 13.382
Authors: Liisa Keltikangas-Järvinen; Kateryna Savelieva; Kim Josefsson; Marko Elovainio; Laura Pulkki-Råback; Markus Juonala; Olli T Raitakari; Mirka Hintsanen Journal: Ann Behav Med Date: 2017-08
Authors: Lisa S Olive; Rohan M Telford; D G Byrne; Walter P Abhayaratna; Richard D Telford Journal: Health Psychol Date: 2017-05-25 Impact factor: 4.267
Authors: Karen A Matthews; Yue-Fang Chang; Kim Sutton-Tyrrell; Daniel Edmundowicz; Joyce T Bromberger Journal: Psychosom Med Date: 2010-07-28 Impact factor: 4.312
Authors: Imke Janssen; Lynda H Powell; Karen A Matthews; Mateusz S Jasielec; Steven M Hollenberg; Joyce T Bromberger; Kim Sutton-Tyrrell; Susan A Everson-Rose Journal: Am J Cardiol Date: 2016-04-05 Impact factor: 2.778
Authors: Karen A Matthews; Laura L Schott; Joyce T Bromberger; Jill M Cyranowski; Susan A Everson-Rose; MaryFran Sowers Journal: Brain Behav Immun Date: 2009-08-14 Impact factor: 7.217
Authors: Lauren B Shomaker; Marian Tanofsky-Kraff; Elizabeth A Stern; Rachel Miller; Jaclyn M Zocca; Sara E Field; Susan Z Yanovski; Van S Hubbard; Jack A Yanovski Journal: Diabetes Care Date: 2011-09-12 Impact factor: 19.112